Literature DB >> 7072720

Bovine protoporphyria: documentation of autosomal recessive inheritance and comparison with the human disease through measurement of heme synthase activity.

J R Bloomer, K O Morton, R J Reuter, G R Ruth.   

Abstract

Protoporphyria is an autosomal dominant disease in man in which protoporphyrin accumulated because of a defect in heme synthase (ferrochelatase) activity. A disease has been described in cattle that has the same manifestations as does the human disease. We measured heme synthase activity in sonicates of cultured skin fibroblasts and whole liver homogenates from animals with protoporphyria, their unaffected parents, and normal cattle in order to examine the mode of inheritance and compare it with human protoporphyria. The mean activity (+/- SEM) in fibroblasts from the three groups was 2.0 +/- 0.4, 47 +/- 12, and 149 +/- 10 pmol heme formed/mg protein per hr, respectively, consistent with autosomal recessive inheritance. Similarly, the levels of heme synthase activity in livers of the parents were intermediate to those of normal animals and of animals with protoporphyria. When compared with normal human fibroblasts and liver, the specific activity of heme synthase in normal bovine tissue was significantly higher. These studies indicate that manifestations of protoporphyria do not occur in cattle unless the animal is homozygous for the gene defect, whereas in humans, the heterozygous condition is sufficient. This is probably because the specific activity of heme synthase in cells of heterozygous animals is not reduced to a level that significantly alters heme metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7072720      PMCID: PMC1685290     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Decreased haem synthetase activity in blood cells of patients with erythropoietic protoporphyria.

Authors:  A F de Goeij; K Christianse; J van Steveninck
Journal:  Eur J Clin Invest       Date:  1975-09-12       Impact factor: 4.686

2.  Erythropoietic protoporphyria. 10 years experience.

Authors:  V A DeLeo; M Poh-Fitzpatrick; M Mathews-Roth; L C Harber
Journal:  Am J Med       Date:  1976-01       Impact factor: 4.965

3.  Reduced ferrochelatase activity: a defect common to porphyria variegata and protoporphyria.

Authors:  D M Becker; J D Viljoen; J Katz; S Kramer
Journal:  Br J Haematol       Date:  1977-06       Impact factor: 6.998

4.  Heme formation from Fe(II) and porphyrin in the absence of ferrochelatase activity.

Authors:  R J Kassner; H Walchak
Journal:  Biochim Biophys Acta       Date:  1973-04-28

5.  The "glucose effect" in erythropoietic protoporphyria.

Authors:  A G Redeker; R E Sterling
Journal:  Arch Intern Med       Date:  1968-05

6.  The effect of diet in variegate (South African genetic) porphyria.

Authors:  M G Perlroth; D P Tschudy; A Ratner; W Spaur; A Redeker
Journal:  Metabolism       Date:  1968-07       Impact factor: 8.694

7.  Diminished erythroid ferrochelatase activity in protoporphyria.

Authors:  S S Bottomley; M Tanaka; M A Everett
Journal:  J Lab Clin Med       Date:  1975-07

8.  Inheritance in protoporphyria. Comparison of haem synthetase activity in skin fibroblasts with clinical features.

Authors:  J R Bloomer; H L Bonkowsky; P S Ebert; M J Mahoney
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

9.  Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts.

Authors:  H L Bonkowsky; J R Bloomer; P S Ebert; M J Mahoney
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias.

Authors:  C J Watson; C A Pierach; I Bossenmaier; R Cardinal
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

View more
  6 in total

1.  The synthesis of murine ferrochelatase in vitro and in vivo.

Authors:  S R Karr; H A Dailey
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

Review 2.  Porphyrias: animal models and prospects for cellular and gene therapy.

Authors:  H de Verneuil; C Ged; S Boulechfar; F Moreau-Gaudry
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

Review 3.  The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.

Authors:  S Taketani; H Fujita
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

4.  Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.

Authors:  S Tutois; X Montagutelli; V Da Silva; H Jouault; P Rouyer-Fessard; K Leroy-Viard; J L Guénet; Y Nordmann; Y Beuzard; J C Deybach
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

5.  Immunochemical studies of ferrochelatase protein: characterization of the normal and mutant protein in bovine and human protoporphyria.

Authors:  J G Straka; H D Hill; J M Krikava; A M Kools; J R Bloomer
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

6.  Bovine congenital erythropoietic protoporphyria in a crossbred limousin heifer in Ireland.

Authors:  Conor G McAloon; Michael L Doherty; Henry O'Neill; Michael Badminton; Eoin G Ryan
Journal:  Ir Vet J       Date:  2015-07-02       Impact factor: 2.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.